Ibrutinib to treat elderly patients with chronic lymphocytic leukaemia
Ibrutinib to treat elderly patients with chronic lymphocytic leukaemia
ASH 2015: New targeted therapies for haematological malignancies
Using epigenetics to manipulate cancer cells
Overcoming the barriers of the P53 dysfunction to cure blood cancers
Experimental oral therapy for ultra high-risk chronic lymphocytic leukaemia shows promise
Study underscores promise of targeted therapies as first-line approach for patients with chronic lymphocytic leukaemia
First targeted therapy for multiple myeloma effective against hard-to-treat disease
First targeted therapy for genetically defined subset of patients with acute myeloid leukaemia significantly improves survival
Study finds new use for rituximab in acute lymphoblastic leukaemia
First targeted therapy for multiple myeloma effective against hard-to-treat disease
First targeted therapy for genetically defined subset with acute myeloid leukaemia significantly improves survival
Immunotherapy makes patients’ tumours "melt away"